Federal State Budgetary Institution 'N.N. Petrov National Medical Research Center of Oncology'

Events

• In the future, the product may be used to treat melanoma

Recent coverage

• Preclinical studies of the oncovaccine CaTeVac completed in Russia — Москва 24